Quarterly report pursuant to Section 13 or 15(d)

MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS

v3.24.1.u1
MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS
3 Months Ended
Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS MARKETABLE SECURITIES AND NON-CURRENT INVESTMENTS
The following is a summary of marketable securities classified as trading and available for sale as of March 31, 2024 and December 31, 2023 (in millions):
Cost Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
March 31, 2024:
Current trading marketable securities:
Equity securities $ $ —  $ —  $
Total trading marketable securities —  — 
Current available-for-sale securities:
U.S. government and agency debt securities 200  —  (2) 198 
Mortgage and asset-backed debt securities —  —  —  — 
Corporate debt securities 32  —  (1) 31 
Non-U.S. government debt securities —  —  —  — 
Total available-for-sale marketable securities 232  —  (3) 229 
Total current marketable securities $ 235  $ —  $ (3) $ 232 
  Cost Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
December 31, 2023:
Current trading marketable securities:
Equity securities $ $ —  $ —  $
Total trading marketable securities —  — 
Current available-for-sale securities:
U.S. government and agency debt securities 963  (4) 961 
Mortgage and asset-backed debt securities —  — 
Corporate debt securities 1,891  (4) 1,891 
Non-U.S. government debt securities —  — 
Total available-for-sale marketable securities 2,864  (8) 2,862 
Total current marketable securities $ 2,868  $ $ (8) $ 2,866 
Investment Impairments
We have concluded that no material impairment losses existed within marketable securities as of March 31, 2024. In making this determination, we considered the financial condition and prospects of each issuer, the magnitude of the losses compared with the cost, the probability that we will be unable to collect all amounts due according to the contractual terms of the security, the credit rating of the security and our ability and intent to hold these investments until the anticipated recovery in market value occurs.
Maturity Information
The amortized cost and estimated fair value of marketable securities as of March 31, 2024 by contractual maturity are shown below (in millions). Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations with or without prepayment penalties.
Cost Estimated
Fair Value
Due in one year or less $ 70  $ 69 
Due after one year through three years 162  160 
Due after three years through five years —  — 
Due after five years —  — 
232  229 
Equity securities
$ 235  $ 232 
Non-Current Investments
We hold non-current investments that are reported within Other Non-Current Assets in our consolidated balance sheets. Cash paid for these investments is included in Other investing activities in our statements of consolidated cash flows.
Equity method investments: As of March 31, 2024 and December 31, 2023, equity securities accounted for under the equity method had a carrying value of $293 and $295 million, respectively.
Other equity securities: Certain equity securities that do not have readily determinable fair values are reported in accordance with the measurement alternative in ASC Topic 321 Investments - Equity Securities. Equity securities accounted for under the measurement alternative had a carrying value of $47 million as of both March 31, 2024 and December 31, 2023.
Other investments: We hold an investment in a variable life insurance policy to fund benefits for the UPS Excess Coordinating Benefit Plan. The investment had a fair market value of $19 million as of both March 31, 2024 and December 31, 2023.
Fair Value Measurements
Marketable securities valued utilizing Level 1 inputs include active exchange-traded equity securities and equity index funds, and most U.S. government debt securities, as these securities all have quoted prices in active markets. Marketable securities valued utilizing Level 2 inputs include asset-backed securities, corporate bonds and municipal bonds. These securities are valued using market corroborated pricing, matrix pricing or other models that utilize observable inputs such as yield curves.
The following table presents information about our investments measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value (in millions):
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total 
March 31, 2024:
Marketable Securities:
U.S. government and agency debt securities $ 198  $ —  $ —  $ 198 
Mortgage and asset-backed debt securities —  —  —  — 
Corporate debt securities —  31  —  31 
Equity securities —  — 
Non-U.S. government debt securities —  —  —  — 
Total marketable securities 198  34  —  232 
Other non-current investments(1)
—  19  —  19 
Total $ 198  $ 53  $ —  $ 251 
(1)    Represents a variable life insurance policy funding benefits for the UPS Excess Coordinating Benefit Plan.

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
December 31, 2023:
Marketable Securities:
U.S. government and agency debt securities $ 961  $ —  $ —  $ 961 
Mortgage and asset-backed debt securities —  — 
Corporate debt securities —  1,891  —  1,891 
Equity securities —  — 
Non-U.S. government debt securities —  — 
Total marketable securities 961  1,905  —  2,866 
Other non-current investments(1)
—  19  —  19 
Total $ 961  $ 1,924  $ —  $ 2,885 
(1)    Represents a variable life insurance policy funding benefits for the UPS Excess Coordinating Benefit Plan.
There were no transfers of investments into or out of Level 3 during the three months ended March 31, 2024 or 2023.